Research advances in mechanism of antiangiogenic therapy combined with immune checkpoint inhibitors for treatment of non-small cell lung cancer.

MLA

Danming He, et al. “Research Advances in Mechanism of Antiangiogenic Therapy Combined with Immune Checkpoint Inhibitors for Treatment of Non-Small Cell Lung Cancer.” Frontiers in Immunology, Oct. 2023, pp. 1–12. EBSCOhost, https://doi.org/10.3389/fimmu.2023.1265865.

APA

Danming He, Lu Wang, Jiachen Xu, Jie Zhao, Hua Bai, & Jie Wang. (2023). Research advances in mechanism of antiangiogenic therapy combined with immune checkpoint inhibitors for treatment of non-small cell lung cancer. Frontiers in Immunology, 1–12. https://doi.org/10.3389/fimmu.2023.1265865

Chicago

Danming He, Lu Wang, Jiachen Xu, Jie Zhao, Hua Bai, and Jie Wang. 2023. “Research Advances in Mechanism of Antiangiogenic Therapy Combined with Immune Checkpoint Inhibitors for Treatment of Non-Small Cell Lung Cancer.” Frontiers in Immunology, October, 1–12. doi:10.3389/fimmu.2023.1265865.